ARCHIVES

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

In Brief: Schmidt Asks NCI Grantees, Contractors To tell Him How They Waste Cancer Money

December 13, 1974

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013